Endocrine Abstracts (2013) 32 P87 | DOI: 10.1530/endoabs.32.P87

Oxidative stress in middle age males with osteoporosis: correlation of hormonal pattern and plasma total antioxidant capacity

Sebastiano Raimondo1, Francesco Ciro Tamburrelli2, Chantal Di Segni1, Mariasara Persano1, Roberto Festa3, Andrea Silvestrini4, Elisabetta Meucci4, Alfredo Pontecorvi1 & Antonio Mancini1


1Division of Endocrinology, Department of Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy; 2Department of Spine Surgery, Catholic University of the Sacred Heart, Rome, Italy; 3Department of Molecular Pathology, Polytechnic University of the Marche, Ancona, Italy; 4Institute of Biochemistry and Clinical Biochemistry, Catholic University of the Sacred Heart, Rome, Italy.


Male idiopathic osteoporosis is an underestimated disease, despite its clinical and social importance. The biochemical mechanisms are still poorly understood even if the interaction between genetic factors and hormone environment (especially gonadal steroids and GH) plays a undoubtful role. In previous studies we demonstrated low plasma total antioxidant capacity (TAC) in hypogonadal patients. The aim of this study was to investigate oxidative stress as risk factor for bone fracture, and its relationships with endocrine milieu.

We enrolled 31 male subjects (36–72 years), all affected by back pain/spine fracture as a consequence of trivial trauma and ten healthy controls (30–48 years). TAC was determined using a colorimetric assay, using the system H2O2-metmyoglobin as source of radicals and a chromogen (ABTS); the latency time (LAG) in the accumulation of ABTS.+, spectroscopically detectable, is proportional to antioxidants concentration. An endocrine evaluation including testosterone, estradiol, insulin, IGF1, PRL, FT3, FT4, TSH levels was also performed. Finally, bone mineral density was assessed by DEXA. Bone metabolic parameters were evaluated (PTH, vitamin D, osteocalcin, and β-cross laps). Statistical evaluation was performed using Mann–Whitney U test.

The prevalence of IGF1 defects (52.8±15.28 ng/ml) was 5/31 (suggesting GH deficiency (GHD), confirmed by GHRH+arginine test). Hypogonadism (mean testosterone levels 2.03±0.46 ng/ml) was present in 4/31. The 22 patients left did not show alterations in the hormonal parameters studied. Despite mean levels of LAG were not different between patients and controls (72.7±8.5 vs 75.0±6.0 s), 12 out of 31 patients had low LAG levels (between 50 and 60 s) irrespective of hormonal milieu. Moreover, when considering parameters of bone metabolism we found significantly lower vitamin D levels in hypogonadal subjects, than in patients with GHD and patients with normal hormonal parameters (10.7±5.8 ng/ml vs 19.7±17.7 and 22.7±9.7 respectively).

These preliminary data suggest a possible involvement of oxidative stress in unexplained fractures even if further investigations are needed to establish a possible correlation with anabolic hormones involved in bone metabolism. Low vitamin D levels could exert a worsening effect on osteoporosis in hypogonadal patients.